Bonus Biogroup Ltd - ESG Rating & Company Profile powered by AI
Other corporations in the rating peer group for Bonus Biogroup Ltd are shown. Detailed Sustainability assessment of Bonus Biogroup Ltd can be accessed by registering for free. This page contains a zero-cost Environmental, Social and Governance report covering Bonus Biogroup Ltd.
Bonus Biogroup Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1967 | Hospira Inc | 0.3 | Low |
1967 | PRA Health Sciences Inc | 0.3 | Low |
1970 | Bonus Biogroup Ltd | 0.0 | Low |
1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CTC Bio Inc | 0.0 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Bonus Biogroup Ltd have an accelerator or VC vehicle to help deliver innovation?
Does Bonus Biogroup Ltd disclose current and historical energy intensity?
Does Bonus Biogroup Ltd report the average age of the workforce?
Does Bonus Biogroup Ltd reference operational or capital allocation in relation to climate change?
Does Bonus Biogroup Ltd disclose its ethnicity pay gap?
Does Bonus Biogroup Ltd disclose cybersecurity risks?
Does Bonus Biogroup Ltd offer flexible work?
Does Bonus Biogroup Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Bonus Biogroup Ltd disclose the number of employees in R&D functions?
Does Bonus Biogroup Ltd conduct supply chain audits?
Does Bonus Biogroup Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Bonus Biogroup Ltd conduct 360 degree staff reviews?
Does Bonus Biogroup Ltd disclose the individual responsible for D&I?
Does Bonus Biogroup Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Bonus Biogroup Ltd disclose current and / or historical scope 2 emissions?
Does Bonus Biogroup Ltd disclose water use targets?
Does Bonus Biogroup Ltd have careers partnerships with academic institutions?
Did Bonus Biogroup Ltd have a product recall in the last two years?
Does Bonus Biogroup Ltd disclose incidents of discrimination?
Does Bonus Biogroup Ltd allow for Work Councils/Collective Agreements to be formed?
Has Bonus Biogroup Ltd issued a profit warning in the past 24 months?
Does Bonus Biogroup Ltd disclose parental leave metrics?
Does Bonus Biogroup Ltd disclose climate scenario or pathway analysis?
Does Bonus Biogroup Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Bonus Biogroup Ltd disclose the pay ratio of women to men?
Does Bonus Biogroup Ltd support suppliers with sustainability related research and development?
Does Bonus Biogroup Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Bonus Biogroup Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Bonus Biogroup Ltd involved in embryonic stem cell research?
Does Bonus Biogroup Ltd disclose GHG and Air Emissions intensity?
Does Bonus Biogroup Ltd disclose its waste policy?
Does Bonus Biogroup Ltd report according to TCFD requirements?
Does Bonus Biogroup Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Bonus Biogroup Ltd disclose energy use targets?
Does Bonus Biogroup Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Bonus Biogroup Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for Bonus Biogroup Ltd
These potential risks are based on the size, segment and geographies of the company.
Bonus BioGroup Ltd., a biotechnology company, develops technology solutions to generate tissue-regenerating bone grafts. It develops tissue-regenerating bone grafts from cells derived from the patient's own cells for the treatment of skeletal disorders, such as bone trauma and arthritis. The company's products include BonoFill injectable bone graft that is suitable for bone repair applications, including jaw bone cysts; and BonoFill pre-designed bone graft, which is used to repair large and segmental bone defects. Its products in pipeline comprise bone grafts for maxillofacial and orthopedic applications; novel nanomaterials technology for tissue regeneration; and large vascularized bone grafts. The company was formerly known as Oceana Advanced Industries Ltd. and changed its name to Bonus BioGroup Ltd. Bonus BioGroup Ltd. was founded in 1981 and is based in Haifa, Israel.